4th Nov 2013 12:41
LONDON (Alliance News) - EKF Diagnostics Holdings PLC said that it had launched four new PointMan DNA research kits Monday.
The kits are used to find companion diagnostics for cancer treatments and are planned for diagnostic registration in Europe in 2014.
EKF develops and manufactures diagnostic instruments for the healthcare market. Its shares were trading down 0.12 pence at 31.62 pence Monday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Ekf Diagnostics